                               SEQUENCE LISTING	

<110> PFENEX INC.
 
<120> METHOD FOR PRODUCING SOLUBLE RECOMBINANT INTERFERON PROTEIN 
      WITHOUT DENATURING

<130> 38194-704.601

<140>
<141>

<150> 61/310,671
<151> 2010-03-04

<160> 7     

<170> PatentIn version 3.5

<210> 1
<211> 166
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 1
Met Ser Tyr Asn Leu Leu Gly Phe Leu Gln Arg Ser Ser Asn Phe Gln 
1               5                   10                  15      


Ser Gln Lys Leu Leu Trp Gln Leu Asn Gly Arg Leu Glu Tyr Cys Leu 
            20                  25                  30          


Lys Asp Arg Met Asn Phe Asp Ile Pro Glu Glu Ile Lys Gln Leu Gln 
        35                  40                  45              


Gln Phe Gln Lys Glu Asp Ala Ala Leu Thr Ile Tyr Glu Met Leu Gln 
    50                  55                  60                  


Asn Ile Phe Ala Ile Phe Arg Gln Asp Ser Ser Ser Thr Gly Trp Asn 
65                  70                  75                  80  


Glu Thr Ile Val Glu Asn Leu Leu Ala Asn Val Tyr His Gln Ile Asn 
                85                  90                  95      


His Leu Lys Thr Val Leu Glu Glu Lys Leu Glu Lys Glu Asp Phe Thr 
            100                 105                 110         


Arg Gly Lys Leu Met Ser Ser Leu His Leu Lys Arg Tyr Tyr Gly Arg 
        115                 120                 125             


Ile Leu His Tyr Leu Lys Ala Lys Glu Tyr Ser His Cys Ala Trp Thr 
    130                 135                 140                 


Ile Val Arg Val Glu Ile Leu Arg Asn Phe Tyr Phe Ile Asn Arg Leu 
145                 150                 155                 160 


Thr Gly Tyr Leu Arg Asn 
                165     


<210> 2
<211> 499
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 2
atgtcgtaca acctgttggg cttcctgcag cggtcctcca actttcaatc gcagaagctg       60

ctgtggcaat tgaatggtcg cctggaatac tgcctgaagg accgcatgaa cttcgacatc      120

cctgaagaga ttaagcaact ccagcagttc cagaaagagg atgcagctct gacgatctat      180

gaaatgctgc agaacatctt cgcgatcttt cgccaggaca gcagcagcac cggttggaac      240

gaaaccattg tcgagaatct gctggccaac gtctatcacc agattaacca cctcaagact      300

gtgctggaag agaagttgga gaaagaagat ttcacgcgtg gcaagttgat gagttcgctg      360

catttgaaac gctactatgg tcgtatcctg cattacctga aggccaaaga atacagccac      420

tgtgcgtgga ccatcgttcg cgtggagatc ctgcgcaact tctacttcat caatcggctc      480

accggttacc tccgcaact                                                   499


<210> 3
<211> 165
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 3
Ser Tyr Asn Leu Leu Gly Phe Leu Gln Arg Ser Ser Asn Phe Gln Ser 
1               5                   10                  15      


Gln Lys Leu Leu Trp Gln Leu Asn Gly Arg Leu Glu Tyr Cys Leu Lys 
            20                  25                  30          


Asp Arg Met Asn Phe Asp Ile Pro Glu Glu Ile Lys Gln Leu Gln Gln 
        35                  40                  45              


Phe Gln Lys Glu Asp Ala Ala Leu Thr Ile Tyr Glu Met Leu Gln Asn 
    50                  55                  60                  


Ile Phe Ala Ile Phe Arg Gln Asp Ser Ser Ser Thr Gly Trp Asn Glu 
65                  70                  75                  80  


Thr Ile Val Glu Asn Leu Leu Ala Asn Val Tyr His Gln Ile Asn His 
                85                  90                  95      


Leu Lys Thr Val Leu Glu Glu Lys Leu Glu Lys Glu Asp Phe Thr Arg 
            100                 105                 110         


Gly Lys Leu Met Ser Ser Leu His Leu Lys Arg Tyr Tyr Gly Arg Ile 
        115                 120                 125             


Leu His Tyr Leu Lys Ala Lys Glu Tyr Ser His Cys Ala Trp Thr Ile 
    130                 135                 140                 


Val Arg Val Glu Ile Leu Arg Asn Phe Tyr Phe Ile Asn Arg Leu Thr 
145                 150                 155                 160 


Gly Tyr Leu Arg Asn 
                165 


<210> 4
<211> 165
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 4
Cys Asp Leu Pro Gln Thr His Ser Leu Gly Ser Arg Arg Thr Leu Met 
1               5                   10                  15      


Leu Leu Ala Gln Met Arg Lys Ile Ser Leu Phe Ser Cys Leu Lys Asp 
            20                  25                  30          


Arg His Asp Phe Gly Phe Pro Gln Glu Glu Phe Gly Asn Gln Phe Gln 
        35                  40                  45              


Lys Ala Glu Thr Ile Pro Val Leu His Glu Met Ile Gln Gln Ile Phe 
    50                  55                  60                  


Asn Leu Phe Ser Thr Lys Asp Ser Ser Ala Ala Trp Asp Glu Thr Leu 
65                  70                  75                  80  


Leu Asp Lys Phe Tyr Thr Glu Leu Tyr Gln Gln Leu Asn Asp Leu Glu 
                85                  90                  95      


Ala Cys Val Ile Gln Gly Val Gly Val Thr Glu Thr Pro Leu Met Lys 
            100                 105                 110         


Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr Phe Gln Arg Ile Thr Leu 
        115                 120                 125             


Tyr Leu Lys Glu Lys Lys Tyr Ser Pro Cys Ala Trp Glu Val Val Arg 
    130                 135                 140                 


Ala Glu Ile Met Arg Ser Phe Ser Leu Ser Thr Asn Leu Gln Glu Ser 
145                 150                 155                 160 


Leu Arg Ser Lys Glu 
                165 


<210> 5
<211> 495
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 5
tgtgacctgc ctcagactca ctccctcggt agccgccgga ccctgatgct gttggcgcag       60

atgcgtaaga tctccctgtt ctcgtgcctg aaagaccgcc atgatttcgg cttcccgcag      120

gaagaattcg ggaaccagtt tcagaaggct gaaaccatcc cagtgctgca cgagatgatc      180

cagcaaattt tcaacctgtt cagcaccaag gacagctcgg ccgcctggga cgaaacgttg      240

ttggacaaat tttacaccga gctgtaccaa caactgaacg atctggaagc atgcgttatt      300

caaggcgtgg gcgtcaccga aacgccgctg atgaaagaag atagcatcct ggccgtgcgt      360

aagtactttc agcgcatcac cctctacctg aaagagaaga agtattcgcc ctgcgcgtgg      420

gaggtcgtcc gcgccgagat catgcggtcc ttcagcctct ccaccaatct gcaggaaagt      480

ctccgctcga aagaa                                                       495


<210> 6
<211> 165
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 6
Cys Asp Leu Pro Gln Thr His Ser Leu Gly Ser Arg Arg Thr Leu Met 
1               5                   10                  15      


Leu Leu Ala Gln Met Arg Arg Ile Ser Leu Phe Ser Cys Leu Lys Asp 
            20                  25                  30          


Arg His Asp Phe Gly Phe Pro Gln Glu Glu Phe Gly Asn Gln Phe Gln 
        35                  40                  45              


Lys Ala Glu Thr Ile Pro Val Leu His Glu Met Ile Gln Gln Ile Phe 
    50                  55                  60                  


Asn Leu Phe Ser Thr Lys Asp Ser Ser Ala Ala Trp Asp Glu Thr Leu 
65                  70                  75                  80  


Leu Asp Lys Phe Tyr Thr Glu Leu Tyr Gln Gln Leu Asn Asp Leu Glu 
                85                  90                  95      


Ala Cys Val Ile Gln Gly Val Gly Val Thr Glu Thr Pro Leu Met Lys 
            100                 105                 110         


Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr Phe Gln Arg Ile Thr Leu 
        115                 120                 125             


Tyr Leu Lys Glu Lys Lys Tyr Ser Pro Cys Ala Trp Glu Val Val Arg 
    130                 135                 140                 


Ala Glu Ile Met Arg Ser Phe Ser Leu Ser Thr Asn Leu Gln Glu Ser 
145                 150                 155                 160 


Leu Arg Ser Lys Glu 
                165 


<210> 7
<211> 495
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 7
tgtgacctgc ctcagactca ctccctcggt agccgccgga ccctgatgct gttggcgcag       60

atgcgtcgca tctccctgtt ctcgtgcctg aaagaccgcc atgatttcgg cttcccgcag      120

gaagaattcg ggaaccagtt tcagaaggct gaaaccatcc cagtgctgca cgagatgatc      180

cagcaaattt tcaacctgtt cagcaccaag gacagctcgg ccgcctggga cgaaacgttg      240

ttggacaaat tttacaccga gctgtaccaa caactgaacg atctggaagc atgcgttatt      300

caaggcgtgg gcgtcaccga aacgccgctg atgaaagaag atagcatcct ggccgtgcgt      360

aagtactttc agcgcatcac cctctacctg aaagagaaga agtattcgcc ctgcgcgtgg      420

gaggtcgtcc gcgccgagat catgcggtcc ttcagcctct ccaccaatct gcaggaaagt      480

ctccgctcga aagaa                                                       495


